Therefore, this present study was designed to investigate whether fludarabine-mediated inhibition of ERCC1-mediated DNA repair could positively impact on SJG-136 ICL patterns and enhance the resulting cytotoxicity of SJG-136 in CLL cells. This evidence concerns the gene ERCC1 and B-cell chronic lymphocytic leukemia.